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Summary
Recent studies have begun to elucidate how the endothelial
lineage is specified from the nascent mesoderm [1, 2].
However, the molecular mechanisms which regulate this
process remain largely unknown. We hypothesized that
Notch signaling might play an important role in specifying
endothelial progenitors from the mesoderm, given that this
pathway acts as a bipotential cell-fate switch on equipotent
progenitor populations in other settings [3, 4]. We found
that zebrafish embryos with decreased levels of Notch
signaling exhibited a significant increase in the number of
endothelial cells, whereas embryos with increased levels
of Notch signaling displayed a reduced number of endothe-
lial cells. Interestingly, there is a concomitant gain of endo-
thelial cells and loss of erythrocytes in embryos with
decreased Notch activity, without an effect on cell prolifera-
tion or apoptosis. Lineage-tracing analyses indicate that
the ectopic endothelial cells in embryos with decreased
Notch activity originate frommesodermal cells that normally
produce erythrocyte progenitors. Taken together, our data
suggest that Notch signaling negatively regulates the
number of endothelial cells by limiting the number of endo-
thelial progenitors within the mesoderm, probably func-
tioning as a cell-fate switch between the endothelial and
the hematopoietic lineages.
Results and Discussion
In order to determine the function of Notch signaling during
the specification of the endothelial lineage, we first evaluated
the effects of decreased Notch activity on endothelial cells
at early stages of zebrafish development. Tg(kdrl:EGFP)s843
[5] embryos were treated with 100 mM DAPT (in 5% DMSO),
a known chemical antagonist of Notch signaling [6], or 5%
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nia, 2011 Zonal Avenue, Los Angeles, CA 90089, USADMSO (vehicle alone) from 6 to 18 hr postfertilization (hpf),
and the number of endothelial nuclei within a single transverse
section of each embryo was quantified. At the tenth somite
level, an average of 6.66 (s = 2.42) endothelial nuclei were
present in embryos treated with DAPT (n = 44), in comparison
to an average of 4.03 (s = 1.27) endothelial nuclei in control
embryos treated with DMSO (n = 30), representing a 65%
increase (analysis of variance [ANOVA], p < 1026) (Figure 1).
Analysis at the fifth somite level yielded similar results (ANOVA,
p < 1025; Figure S1, available online). The observed increase
in the number of GFP-positive endothelial cells in DAPT-
treated embryos does not appear to be a transgene-depen-
dent phenomenon because similar increases were observed
in other transgenic lines, such as Tg(fli1a:nGFP)y7 [7] and
Tg(kdrl:Ras-mCherry)s896 [8], that have labeled endothelial
cells (data not shown). In addition, a significant increase in
the number of endothelial cells was also observed in homozy-
gous mindbomb (mibta56b) mutant embryos, which lack an E3
ubiquitin ligase required for activation of Notch by Delta [9]
(Figure S2).
We utilized fluorescence-activated cell sorting (FACS) to
better quantify the effect of DAPT treatment on the entire
endothelial population. For minimization of interference from
the GFP expression in the pharyngeal endoderm of the
Tg(kdrl:EGFP)s843 embryos [5], casanovas4 (cass4) mutant
embryos [10] were used. Previous studies have shown that
the cass4 mutant embryos completely lack endoderm, with
little effect on hematovascular development [10]. We found
that DAPT-treated embryos contained 55% more GFP-posi-
tive endothelial cells in comparison to DMSO-treated embryos
(Figure S3). Therefore, Notch signaling appears to negatively
regulate the number of endothelial cells throughout the entire
embryo. Consistent with our findings, multiple notch and delta
genes are expressed in the zebrafish gastrula (Figure S4).
Previous studies have demonstrated that Notch signaling is
required at multiple time points for regulation of various
aspects of vascular development [11–15]. To define the time
frame in which Notch signaling modulates the number of endo-
thelial cells, we treated embryos with DAPT during distinct
stages of development. Embryos treated from 6 to 10 hpf
and from 14 to 18 hpf did not exhibit obvious changes in the
number of endothelial cells. In contrast, embryos incubated
with DAPT from 10 to 14 hpf displayed an increase in the
number of endothelial cells similar to those continuously
treated from 6 to 18 hpf (Figure S5 and data not shown). Inter-
estingly, decreased Notch activity at this stage did not inhibit
the differentiation of arterial endothelial cells (as determined
by EphrinB2a expression), suggesting that the function of
Notch signaling in limiting the number of the endothelial cells
can be separated from the previously known function in
promoting arterial endothelial cell fate.
For testing whether increased Notch activity might cause
the opposite effect on the number of endothelial cells,
Tg(hsp70l:Gal4)kca4;Tg(UAS:myc-notch:intra)kca3 [16] embryos
were heat-shocked at shield stage (6 hpf), inducing the
expression of the intracellular domain of Notch (NICD).
Embryos expressing the NICD (detected by presence of the
myc epitope) exhibited a significant decrease in the number
Figure 1. Notch Signaling Negatively Regulates the Number of Endothelial Cells during Zebrafish Development
(A) Transverse sections of 18 hpf embryos, DMSO- or DAPT-treated, visualized for TOPRO (white), kdrl:GFP (green), and phalloidin (red).
(B) Quantification of endothelial nuclei per focal plane in DMSO-treated (n = 30) or DAPT-treated (n = 44) embryos.
(C) Transverse sections of 18 hpf phenotypic wild-type siblings and Tg(hsp70l:Gal4)kca4;Tg(UAS:myc-NICD)kca3 embryos visualized for TOPRO (white),
kdrl:GFP (green), and c-Myc as a surrogate measure for NICD expression (red).
(D) Quantification of endothelial nuclei per focal plane in phenotypic wild-type (n = 31) and NICD-overexpressing (n = 28) embryos. Embryos treated with
DAPT contained 6.66 (s = 2.42) endothelial nuclei per section, whereas those treated with DMSO had 4.03 (s = 1.27) endothelial nuclei (ANOVA, p <
1026). Conversely, embryos overexpressing the NICD contained 3.14 (s = 0.80) endothelial nuclei, in comparison to 4.42 (s = 1.09) nuclei per section in pheno-
typic wild-type siblings (ANOVA, p < 1025), suggesting that Notch signaling negatively regulates endothelial cell number.
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1617of endothelial cells in comparison to the non-heat-shocked
control siblings (Figure 1C). An average of 4.42 (s = 1.09)
endothelial nuclei were present in the control embryos (n =
31), whereas an average of 3.14 (s = 0.80) endothelial nuclei
were found in the embryos expressing NICD (n = 28), represent-
ing a 29% loss in endothelial cell number (ANOVA, p < 1025;
Figure 1D). Therefore, increased Notch activity leads to
a reduction in the number of endothelial cells. Taken together,
our results show that Notch signaling negatively regulates
the number of the endothelial cells during early zebrafish
development.
To determine whether the observed gain of endothelial cells
in embryos with decreased Notch activity was caused by
changes in cell proliferation or cell death, we measured
these rates in DAPT- and DMSO-treated embryos at 12, 14,
and 16 hpf. Neither BrdU incorporation nor staining with the
mitotic marker phospho-Histone3 showed any discernabledifferences in cell proliferation within the endothelial cells
between DAPT- and DMSO-treated embryos (Figure S6). In
addition, Acridine Orange and anti-Caspase3/8 staining did
not show any differences in cell death between the two groups
(data not shown), suggesting that these processes are not
likely to be the major cause for the increased number of endo-
thelial cells in embryos with decreased Notch activity.
We then speculated that the excess endothelial cells may
have resulted from expansion of the endothelial progenitor
population within the mesoderm, potentially at the expense
of other related lineages. To test this hypothesis, we investi-
gated the effects of modulated Notch signaling on the hemato-
poietic lineage, which develops in close spatiotemporal
proximity to the endothelial lineage during embryogenesis [2,
17]. In DAPT-treated embryos, the expression levels of hema-
topoietic markers, such as gata1 [18], ikaros [19], and draculin
[20], were drastically decreased in comparison to those of
Figure 2. Notch Signaling Positively Regulates the Number of Hematopoietic Cells during Zebrafish Development
(A) Whole-mount RNA in situ hybridization showing the expression of gata1 in 18 hpf DMSO-treated or DAPT-treated embryos. Two additional markers,
krox20 and otx1, which label the hindbrain and neuroectoderm, respectively, were used as positive controls. Notice the reduced expression of gata1 in
DAPT-treated embryos (black arrow).
(B) Transverse sections of 18 hpf DMSO- or DAPT-treated embryos visualized for TOPRO (white), gata1:GFP (green), and phalloidin (red).
(C) Quantification of the hematopoietic nuclei per focal plane in DMSO-treated (n = 27) or DAPT-treated (n = 19) embryos.
(D) Transverse sections of 18 hpf phenotypic wild-type siblings and Tg(hsp70l:Gal4)kca4;Tg(UAS:myc-NICD)kca3 embryos visualized for TOPRO (white),
gata1:GFP (green), and c-Myc as a surrogate measure for NICD expression (red).
(E) Quantification of the hematopoietic nuclei per focal plane in phenotypic wild-type siblings (n = 28) and NICD-overexpressing embryos (n = 23). DAPT-
treated embryos contained 4.89 (s = 2.15) erythrocyte nuclei, in comparison to 8.07 (s = 2.38) nuclei in DMSO-treated embryos (ANOVA, p < 1024).
Conversely, embryos overexpressing the NICD contained 9.89 (s = 2.53) erythrocyte nuclei, in comparison to 6.72 (s = 1.43) nuclei per section in phenotypic
wild-type siblings (ANOVA, p < 1026), indicating that Notch signaling positively modulates the number of hematopoietic cells.
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1618DMSO-treated embryos (Figure 2A and data not shown). The
reduced expression of these in situ markers appears to be
specific to the hematopoietic lineage, because nonhemato-
poietic markers krox20 [21] and otx1 [22] (Figure 2A) show
equivalent levels of expression.
To confirm that the reduced expression of hematopoietic
lineage markers detected by in situ hybridization is the result
of a decreased number of hematopoietic cells, we used
Tg(gata1:EGFP)la781 [23] embryos to count the number of
GFP-positive erythrocytes in DAPT- and DMSO-treated
embryos. Given that we observed a drastic increase in the
number of endothelial cells in the posterior half of the DAPT-
treated embryos, where the majority of hematopoietic cells
are erythrocytes, counting the number of gata1:GFP-positive
cells would serve as a simple surrogate measure for identifying
any discernable changes in the number of hematopoietic cells.In comparison to an average of 8.07 (s = 2.38) erythrocyte
nuclei per section in DMSO-treated embryos (n = 27), embryos
treated with DAPT (n = 19) had an average of 4.89 (s = 2.15)
erythrocyte nuclei (Figure 2B), approximately a 39% decrease
(ANOVA, p < 1024; Figure 2C). Conversely, embryos express-
ing the NICD exhibited a significant increase in the number
of hematopoietic cells in comparison to control siblings
(ANOVA, p < 1026; Figures 2D and 2E).
Unlike the hematopoietic lineage, no discernable changes in
the number of somitic (detected with S58 and F59 antibodies
[24]) or pronephric duct (Tg(pax2a:GFP)e1 [25]) cells were
detected in embryos treated with DAPT, suggesting that the
contribution of progenitors giving rise to other nonaxial meso-
dermal lineages is negligible (Figure S7 and data not shown).
To further characterize the effects of perturbed Notch
signaling on the endothelial and hematopoietic lineages,
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Figure 3. Reduced Notch Activity Causes an Increase of Endothelial Cells at the Expense of Hematopoietic Cells
(A) Transverse sections of 18 hpf DMSO- or DAPT-treated embryos, visualized for TOPRO (white), kdrl:mCherry (red), and gata1:GFP (green). DAPT-treated
embryos exhibited a concomitant gain of endothelial cells and loss of hematopoietic cells.
(B) Transverse sections of 20 hpf DMSO- or DAPT-treated phenotypic bloodless (bds) mutant embryos, visualized for TOPRO (white), kdrl:GFP (green), and
phalloidin (red).
(C) Quantification of the number of endothelial nuclei per focal plane in DMSO-treated bds (n = 22), DAPT-treated bds (n = 20), and DAPT-treated wild-type
sibling (n = 24) embryos. DAPT treatment in embryos lacking primitive hematopoietic cells (bds + DAPT) did not result in a change in the number of endo-
thelial cells, suggesting that the ectopic endothelial cells observed in DAPT-treated wild-type embryos might have originated from cells that normally
produce hematopoietic cells.
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1619we treated Tg(kdrl:Ras-mCherry)s896;Tg(gata1:EGFP)la781
embryos with DAPT. Interestingly, the embryos exhibited
a concomitant loss of erythrocytes and gain of endothelial
cells (Figure 3A), suggesting that Notch signaling might regu-
late the number of endothelial and hematopoietic cells during
the same developmental stages. For investigation of the possi-
bility that there is a transformation of hematopoietic progeni-
tors into endothelial progenitors at early stages in embryos
with compromised Notch signaling, homozygous bloodless
(bds) mutant embryos were treated with DAPT. The bds muta-
tion obliterates all primitive hematopoietic cells via lineage-
specific apoptosis, without affecting the endothelial lineage
[26]. Thus, if hematopoietic progenitors within the mesoderm
are transformed to endothelial progenitors as a result of
decreased Notch activity, there should be no discernable
change in the number of endothelial cells in the bds mutant
embryos.In DAPT-treated bds mutant embryos (n = 20), an average of
6.05 (s = 1.32) endothelial nuclei were present per section, and
DMSO-treated bds mutant embryos (n = 22) and DAPT-treated
phenotypic wild-type siblings (n = 24) contained an average of
5.95 (s = 1.13) and 8.04 (s = 2.36) endothelial nuclei, respec-
tively (Figure 3B). Thus, we found no significant difference in
the number of endothelial cells in bds mutant embryos treated
with DAPT (ANOVA, p < 0.80; Figure 3C). These data suggest
that decreased Notch activity causes a transformation of
hematopoietic progenitors to endothelial progenitors and
that Notch signaling might function as a cell-fate switch
between the two lineages.
For further testing of the function of Notch signaling as
a cell-fate switch between the endothelial and the hematopoi-
etic lineages, lineage-tracing experiments were performed
[2]. Single-cell-stage embryos were injected with DMNB-
caged fluorescein-conjugated dextran. At shield stage,
00.5
1
1.5
2
D
D
M
S
O
10
0 
µM
 D
A
P
T
TOPRO kdrl:GFP fluorescein merged
BA
Chemical treatment
Confocal analyses
& quantification
UV
E
C
s
 w
it
h
 
u
n
c
a
g
e
d
 
f
l
u
o
r
e
s
c
e
i
n
C
0.16 0.37
1.61 1.01
DMSO               100µM DAPT
kdrl gata1
+
Notch
Endothelial
Progenitors
Hematopoietic
Progenitors
Mesodermal
Progenitors
Endothelial
Cells
Erythrocytes
Figure 4. Notch Signaling Functions as a Cell-Fate Switch between the Endothelial and the Hematopoietic Lineages in the Nascent Mesoderm
(A) Experimental scheme of the lineage-tracing experiment. Single-cell-stage embryos were injected with DMNB-caged fluorescein-conjugated dextran. At
shield stage, ten cells within the ventral margin, which predominantly gives rise to hematopoietic cells, were uncaged with UV irradiation. Subsequently,
embryos were treated with either DMSO or DAPT until 18 hpf.
(B) Transverse sections of 18 hpf embryos treated with DMSO or DAPT after uncaging, visualized for TOPRO (white), kdrl:GFP (green), and uncaged fluo-
rescein (red). White arrowheads point to endothelial cells that contain uncaged fluorescein in DAPT-treated embryos.
(C) Quantification of the number of endothelial nuclei with uncaged fluorescein per focal plane in embryos treated with DMSO (n = 18) or DAPT (n = 13).
Embryos treated with DAPT contained 1.61 (s = 1.01) fluorescein-positive endothelial cells, in comparison to 0.16 (s = 0.37) in DMSO-treated embryos.
(D) Our proposed model: Notch signaling negatively regulates endothelial cell number by limiting the mesodermal cells that can differentiate into endothelial
progenitors. Attenuated Notch activity causes mesodermal cells with hematopoietic potential to differentiate into endothelial progenitors, thus increasing
the number of endothelial cells.
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1620approximately ten cells within the ventral margin of the zebra-
fish gastrula, which predominantly generates the primitive
hematopoietic lineage, were uncaged with UV irradiation.
Subsequently, embryos were treated with either DAPT or
DMSO (Figure 4A). If there is a direct transformation of hemato-
poietic progenitors to endothelial progenitors as a result of
decreased Notch activity, the increased contribution to the
endothelial lineage from the ventral margin should be detected.
Because the cells from the ventral marginal zone rarely
contribute to the endothelial lineage [2], an average of 0.16
(s = 0.37) endothelial cells per focal plane contained uncaged
fluorescein in DMSO-treated embryos (n = 18) (Figures 4B
and 4C). In contrast, in DAPT-treated embryos (n = 13), an
average of 1.61 (s = 1.01) endothelial cells per focal plane
showed colocalization with uncaged fluorescein (Figures 4B
and 4C). These data support a model in which hematopoietic
progenitors within the ventral margin of the zebrafish gastrula
are transformed to endothelial progenitors upon the inhibition
of Notch signaling, eventually leading to an increased number
of endothelial cells (Figure 4D).
Considering the existence of common progenitors for the
endothelial and hematopoietic lineages in zebrafish, it istempting to speculate that Notch signaling might function
as a bipotential cell-fate switch for the two lineages by
regulating the hemangioblasts [2], resulting in descendents
preferentially adopting an endothelial fate. However, the
observed magnitude of increase in endothelial cells after inhi-
bition of Notch signaling suggests that the contribution of such
an event would be negligible, although we cannot exclude the
possibility.
Conclusion
Our experiments provide evidence that Notch signaling nega-
tively regulates the number of endothelial cells by modulating
the specification of endothelial progenitors. This novel func-
tion of Notch signaling can be separated from a previously
known function in promoting the differentiation of arterial
endothelial cells during later stages of development. In addi-
tion, our data indicates that the effect of Notch signaling on
endothelial cell number is the result of the direct transforma-
tion of hematopoietic progenitors into endothelial progenitors.
Taken together, our results suggest that Notch signaling
Notch Negatively Regulates the Endothelial Lineage
1621functions as a cell-fate switch between the endothelial and the
hematopoietic lineages within the nascent mesoderm.
Experimental Procedures
Zebrafish Husbandry, Morpholino Injection, and Chemical and Heat-
Shock Treatments
Zebrafish (Danio rerio) embryos were obtained from the University of North
Carolina, Chapel Hill (UNC-CH) Zebrafish Aquaculture Core Facility and
raised as previously described [26]. The following mutant and transgenic
lines were used: bdsa75 [27], cass4 [10], mibta56b [7], Tg(gata1:EGFP)la781
[23], Tg(hsp70l:Gal4)kca4 [16], Tg(fli1a:nGFP)y7 [8], Tg(kdrl:EGFP)s843 [5],
Tg(kdrl:Ras-mCherry)s896 [9], Tg(pax2a:GFP)e1 [24], and Tg(UAS:myc-
notch:intra)kca3 [16]. Homozygous mibta56a embryos were identified by
PCR, and homozygous bdsa75 embryos were identified on the basis of the
lack of ikaros expression by RT-PCR.
Embryos were treated with 100 mM DAPT (CalBiochem) as previously
described [6]. Embryos were treated from 6 to 18 hpf, unless noted other-
wise, and subsequently fixed in 4% paraformaldehyde (PFA) overnight
before processing. So that ectopic Notch signaling would be induced,
embryos from crosses between Tg(hsp70l:Gal4)kca4/+ and Tg(UAS:myc-
notch:intra)kca3/+;Tg(kdrl:EGFP)s843 individuals were raised at 28C until
shield stage (6 hpf) and subjected to treatment at 40C for 30 min. Bright-
field microscopy and myoD [28] in situ hybridization were used for verifying
that the treated embryos exhibited no developmental delays in comparison
to the control embryos (Figure S8).
Immunohistochemistry, In Situ Hybridization, and BrdU Incorporation
Immunohistochemistry and whole-mount in situ hybridization were per-
formed as previously described [5]. The antibodies and riboprobes used
can be found in the Supplemental Data. Polymerized actin was visualized
by phalloidin (Molecular Probes) at 1:300, and nuclei were visualized with
TOPRO (Molecular Probes) at 1:10,000. For immunohistochemistry, pro-
cessed samples were mounted in Vectashield (Vector Laboratories) and
the images were acquired with a Zeiss 510 Meta confocal microscope
(Michael Hooker Microscopy Facility, UNC-CH) or a Zeiss LSM5 Pascal
confocal microscope. For whole-mount in situ hybridization, embryos
were mounted in benzylbenzoate:benzyl alcohol and documented with
Zeiss Axiocam.
For BrdU incorporation, homozygous Tg(kdrl:EGFP)s843 embryos were
treated with DAPT or DMSO from 10 to 18 hpf and also incubated in
10 mM BrdU in 5% DMSO from 14 to 16 hpf. At 18 hpf, embryos were fixed
in 4% paraformaldehyde overnight and then incubated in rat monoclonal
anti-BrdU followed by anti-rat Alexa Fluor 568.
Lineage Tracing
Lineage tracing was performed as previously described [2]. In brief,
Tg(kdrl:EGFP)s843 embryos were injected with 4.6 nl of 0.2% DNMB-caged,
biotinylated, lysine-fixable fluorescein dextran (Molecular Probes) in 0.2 M
KCl and allowed to develop until shield stage (6 hpf). The cells located in
the first three vegetal tiers of the ventral margin were activated with pulses
from a 360 nm laser focused through a 20X objective. Embryos were then
treated with DAPT or DMSO and fixed at 18 hpf. To detect activated fluores-
cein and distinguish it from GFP, we incubated embryos in biotinylated
rabbit IgG FITC antibody followed by Alexa Fluor 568 Streptavidin (Molec-
ular Probes).
ANOVA
The data were analyzed with one-way ANOVA for the effect of different treat-
ments on the number of cells of interest. A p value smaller than 0.01 was
regarded as significant.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and
eight figures and can be found with this article online at http://www.cell.
com/current-biology/supplemental/S0960-9822(09)01624-8.
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